Maria A. Cursino

126, Tessália Vieira De Camargo Street
Campinas, SP 13083887, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer.

miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer.

Journal: Frontiers in pharmacology

Published: August 09, 2023

Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin.

Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin.

Journal: International journal of molecular sciences

Published: June 07, 2023

Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications.

Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications.

Journal: International journal of molecular sciences

Published: November 11, 2022

Answer to "REPLY to Association between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome".

Answer to "REPLY to Association between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome".

Journal: Journal of thrombosis and thrombolysis

Published: April 03, 2022

Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome.

Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome.

Journal: Journal of thrombosis and thrombolysis

Published: June 09, 2021

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.

Journal: BMC cancer

Published: February 28, 2021

Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.

Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.

Journal: Lupus

Published: January 29, 2021

Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life.

Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life.

Journal: Anti-cancer drugs

Published: February 29, 2020

Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.

Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.

Journal: Journal of clinical pharmacy and therapeutics

Published: September 26, 2018

Brazil's resolutions to regulate the sale of antibiotics: Impact on consumption and Escherichia coli resistance rates.

Brazil's resolutions to regulate the sale of antibiotics: Impact on consumption and Escherichia coli resistance rates.

Journal: Journal of global antimicrobial resistance

Published: March 08, 2017

Non-multidrug-resistant, methicillin-resistant Staphylococcus aureus in a neonatal unit.

Non-multidrug-resistant, methicillin-resistant Staphylococcus aureus in a neonatal unit.

Journal: The Pediatric infectious disease journal

Published: June 04, 2014

Performance of surveillance cultures at different body sites to identify asymptomatic Staphylococcus aureus carriers.

Performance of surveillance cultures at different body sites to identify asymptomatic Staphylococcus aureus carriers.

Journal: Diagnostic microbiology and infectious disease

Published: June 05, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026